<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK550349" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK550349/" /><meta name="ncbi_pagename" content="Fructose-1,6-Bisphosphatase Deficiency - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Fructose-1,6-Bisphosphatase Deficiency - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Fructose-1,6-Bisphosphatase Deficiency" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2019/12/05" /><meta name="citation_author" content="Sunita Bijarnia-Mahay" /><meta name="citation_author" content="Sameer Bhatia" /><meta name="citation_author" content="Veronica Arora" /><meta name="citation_pmid" content="31804789" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK550349/" /><meta name="citation_keywords" content="FBP1 Deficiency" /><meta name="citation_keywords" content="FBPase Deficiency" /><meta name="citation_keywords" content="Fructose 1,6 Diphosphatase Deficiency" /><meta name="citation_keywords" content="FBP1 Deficiency" /><meta name="citation_keywords" content="FBPase Deficiency" /><meta name="citation_keywords" content="Fructose 1,6 Diphosphatase Deficiency" /><meta name="citation_keywords" content="Fructose-1,6-bisphosphatase 1" /><meta name="citation_keywords" content="FBP1" /><meta name="citation_keywords" content="Fructose-1,6-Bisphosphatase Deficiency" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Fructose-1,6-Bisphosphatase Deficiency" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Sunita Bijarnia-Mahay" /><meta name="DC.Contributor" content="Sameer Bhatia" /><meta name="DC.Contributor" content="Veronica Arora" /><meta name="DC.Date" content="2019/12/05" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK550349/" /><meta name="description" content="Fructose-1,6-bisphosphatase (FBP1) deficiency is characterized by episodic acute crises of lactic acidosis and ketotic hypoglycemia, manifesting as hyperventilation, apneic spells, seizures, and/or coma. Acute crises are most common in early childhood; nearly half of affected children have hypoglycemia in the neonatal period (especially the first 4 days) resulting from deficient glycogen stores. Factors known to trigger episodes include fever, fasting, decreased oral intake, vomiting, infections, and ingestion of large amounts of fructose." /><meta name="og:title" content="Fructose-1,6-Bisphosphatase Deficiency" /><meta name="og:type" content="book" /><meta name="og:description" content="Fructose-1,6-bisphosphatase (FBP1) deficiency is characterized by episodic acute crises of lactic acidosis and ketotic hypoglycemia, manifesting as hyperventilation, apneic spells, seizures, and/or coma. Acute crises are most common in early childhood; nearly half of affected children have hypoglycemia in the neonatal period (especially the first 4 days) resulting from deficient glycogen stores. Factors known to trigger episodes include fever, fasting, decreased oral intake, vomiting, infections, and ingestion of large amounts of fructose." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK550349/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/fructose1-6-def/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK550349/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE890F24E04071E10000000005CC0296.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK550349_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK550349_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/ftd-chmp2b/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/fryns/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK550349_"><span class="title" itemprop="name">Fructose-1,6-Bisphosphatase Deficiency</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: FBP1 Deficiency; FBPase Deficiency; Fructose 1,6 Diphosphatase Deficiency</div><p class="contrib-group"><span itemprop="author">Sunita Bijarnia-Mahay</span>, MBBS, DCH, DNB, <span itemprop="author">Sameer Bhatia</span>, MBBS, MD, and <span itemprop="author">Veronica Arora</span>, MBBS, MS, DNB (OBG).</p><a data-jig="ncbitoggler" href="#__NBK550349_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK550349_ai__"><div class="contrib half_rhythm"><span itemprop="author">Sunita Bijarnia-Mahay</span>, MBBS, DCH, DNB<div class="affiliation small">Sir Ganga Ram Hospital<br />New Delhi, India<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.liamg@ainrajib" class="oemail">moc.liamg@ainrajib</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Sameer Bhatia</span>, MBBS, MD<div class="affiliation small">Sir Ganga Ram Hospital<br />New Delhi, India<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.liamg@aitahbreemasrd" class="oemail">moc.liamg@aitahbreemasrd</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Veronica Arora</span>, MBBS, MS, DNB (OBG)<div class="affiliation small">Sir Ganga Ram Hospital<br />New Delhi, India<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.liamg@aroraacinorev" class="oemail">moc.liamg@aroraacinorev</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">December 5, 2019</span>.</p><p><em>Estimated reading time: 20 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="fructose1-6-def.Summary" itemprop="description"><h2 id="_fructose1-6-def_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Fructose-1,6-bisphosphatase (FBP1) deficiency is characterized by episodic acute crises of lactic acidosis and ketotic hypoglycemia, manifesting as hyperventilation, apneic spells, seizures, and/or coma. Acute crises are most common in early childhood; nearly half of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children have hypoglycemia in the neonatal period (especially the first 4 days) resulting from deficient glycogen stores. Factors known to trigger episodes include fever, fasting, decreased oral intake, vomiting, infections, and ingestion of large amounts of fructose.</p><p>In untreated individuals, symptoms worsen progressively as continued catabolism leads to multiorgan failure (especially liver, brain, and later heart). Morbidity and mortality are high. Sepsis, blindness, and Reye syndrome-like presentation have been reported.</p><p>In between acute episodes, children are asymptomatic. While the majority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children have normal growth and psychomotor development, a few have intellectual disability, presumably due to early and prolonged hypoglycemia.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of FBP1 deficiency is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with suggestive clinical and metabolic findings by identification of EITHER <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>FBP1</i> pathogenic variants on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> OR deficient fructose-1,6-bisphosphatase 1 (FBP1) activity in liver or mononuclear white blood cells. Molecular genetic testing is generally preferred because of its widespread availability and accuracy.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Intervention (oral or IV glucose) should take place early in an acute crisis while the blood glucose is normal due to the possibility of delayed hypoglycemia, which only occurs relatively late in the course of acute metabolic decompensation.</p><p>The mainstay of routine daily management is prevention of hypoglycemia by avoiding fasting (including use of uncooked cornstarch overnight), consuming frequent meals, and appropriate management of acute intercurrent illnesses.</p><p><i>Prevention of primary manifestations:</i> Routine daily management to prevent hypoglycemia, attention to agents/circumstances to avoid, and routine immunizations, including annual influenza vaccine to reduce the risk of infection, which can precipitate hypoglycemia.</p><p><i>Surveillance:</i> Long-term monitoring of developmental milestones in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children and quality of life issues for affected individuals and their parents/caregivers; monitoring for excessive weight gain at each visit.</p><p><i>Agents/circumstances to avoid:</i> Food items or medicines that contain fructose, sucrose, glycerol, and/or sorbitol, especially during acute crisis in infancy or early childhood. Although small amounts of fructose (&#x02264;2 g/kg/day) are generally well tolerated, single ingestion of high dose of fructose (&#x0003e;1g/kg) is harmful, especially in younger children. Fructose tolerance testing ("fructose challenge") to diagnose FBP1 deficiency can be hazardous and should not be performed.</p><p><i>Evaluation of relatives at risk:</i> When the <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> <i>FBP1</i> variants are known, it is appropriate to clarify the genetic status of apparently asymptomatic older and younger at-risk sibs of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual in order to identify as early as possible those who would benefit from prompt initiation of preventive measures.</p><p><i>Pregnancy management:</i> For a pregnant woman with FBP1 deficiency, consider referral to a high-risk obstetric center and consultation with a metabolic physician. Home glucose monitoring and consumption of uncooked cornstarch at night as needed as carbohydrate requirements increase during pregnancy. During labor, continuous glucose infusion is recommended to maintain euglycemia.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>FBP1 deficiency is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. When both parents are known to be <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for an <i>FBP1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Once the <i>FBP1</i> pathogenic variants have been identified in an affected family member, <a class="def" href="/books/n/gene/glossary/def-item/carrier-testing/">carrier testing</a> for at-risk relatives, prenatal testing for a pregnancy at increased risk, and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-testing/">preimplantation genetic testing</a> are possible.</p></div></div><div id="fructose1-6-def.Diagnosis"><h2 id="_fructose1-6-def_Diagnosis_">Diagnosis</h2><p>Formal diagnostic criteria for fructose-1,6-bisphosphatase (FBP1) deficiency have not been established.</p><div id="fructose1-6-def.Suggestive_Findings"><h3>Suggestive Findings</h3><p>FBP1 deficiency <b>should be suspected</b> in individuals with the following characteristic clinical features and metabolic findings.</p><p><b>Clinical features</b></p><ul><li class="half_rhythm"><div>Episodes of acute crisis may manifest as hyperventilation, apneic spells, seizures, and/or coma, most commonly in neonates and infants. The course of illness is precipitous and may be lethal, especially in neonates and infants.</div></li><li class="half_rhythm"><div>Other features can include episodic irritability, tachycardia, hypotonia, and hyperhidrosis.</div></li><li class="half_rhythm"><div>Hepatomegaly is common.</div></li><li class="half_rhythm"><div>Inter-crisis periods are uneventful with normal development and growth.</div></li></ul><p><b>Metabolic findings.</b> A strong clinical suspicion should arise in individuals with recurrent episodes of ketotic hypoglycemia with lactic acidosis and urinary organic acid analysis showing a glycerol and glycerol-3-phosphate peak. Although this combination is fairly specific for FBP1 deficiency, establishing the diagnosis requires enzyme assay and/or <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a href="#fructose1-6-def.Establishing_the_Diagnos">Establishing the Diagnosis</a>).</p><ul><li class="half_rhythm"><div>Hypoglycemia (plasma glucose &#x0003c;40mg/dL in neonates; &#x0003c;60 mg/dL in older infants, children, and adults; reference range 70-120 mg/dL)</div></li><li class="half_rhythm"><div>High anion-gap metabolic acidosis</div><ul><li class="half_rhythm"><div>Lactic acidemia (plasma lactate &#x0003e;2.5 mmol/L; reference range: 0.5-2.2 mmol/L) with possible elevated lactate:pyruvate ratio and hyperalaninemia.</div></li><li class="half_rhythm"><div>Ketosis (individuals with low ketones have been reported)</div></li></ul></li><li class="half_rhythm"><div>Elevated glycerol 3-phosphate is an important biomarker for this disorder on urine organic acid analysis. Glycerol 3-phosphate is more specific as glycerol is also elevated in glycerol kinase deficiency (see <a href="/books/n/gene/ahc/"><i>NROB1</i>-Related Adrenal Hypoplasia Congenita</a>) [<a class="bk_pop" href="#fructose1-6-def.REF.nakai.1993.408">Nakai et al 1993</a>]. It is important to collect the urine sample in the period of crisis, as the glycerol 3-phosphate level returns to normal once the individual is in the well state [<a class="bk_pop" href="#fructose1-6-def.REF.moey.2018.397">Moey et al 2018</a>].</div></li><li class="half_rhythm"><div>Pseudo-hypertriglyceridemia. Although plasma triglycerides are commonly increased, it is not the triglycerides but the glycerol levels that are high (often referred to as "pseudo-hypertriglyceridemia"). The commonly available biochemical assays for plasma triglycerides cannot differentiate glycerol from triglycerides, and hence overestimate the triglyceride levels due to the high concentration of glycerol in plasma [<a class="bk_pop" href="#fructose1-6-def.REF.afroze.2013.1249">Afroze et al 2013</a>]. Glycerol blanking methods can be used to measure the true levels of triglycerides [<a class="bk_pop" href="#fructose1-6-def.REF.cole.1990.1267">Cole 1990</a>].</div></li><li class="half_rhythm"><div>Hyperuricemia (plasma uric acid &#x0003e;5.0 mg/dL; reference range 2.0-5.0 mmol/L</div></li><li class="half_rhythm"><div>Increased free fatty acids (in some cases)</div></li></ul></div><div id="fructose1-6-def.Establishing_the_Diagnos"><h3>Establishing the Diagnosis</h3><p>The diagnosis of fructose-1,6-bisphosphatase 1 deficiency <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with suggestive clinical and metabolic findings by identification of EITHER <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>FBP1</i> pathogenic variants on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (<a href="https://www.ncbi.nlm.nih.gov/books/NBK333439/table/hfi.T.summary_of_molecular_genetic_testi/?report=objectonly" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Table 1</a>) OR deficient fructose-1,6-bisphosphatase 1 (FBP1) activity in liver or mononuclear white blood cells. Molecular genetic testing is generally preferred because of its widespread availability and accuracy.</p><div id="fructose1-6-def.Molecular_Genetic_Testin"><h4>Molecular Genetic Testing</h4><p>When the clinical and metabolic findings suggest the diagnosis of fructose-1,6-bisphosphatase deficiency, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>FBP1</i> detects small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-gene deletions/duplications are not detected. Perform <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> first. If only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found, perform gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> to detect intragenic deletions or duplications.</div><div class="half_rhythm">Note: Pathogenic variants reported frequently in individuals of certain ancestries are noted in <a class="figpopup" href="/books/NBK550349/table/fructose1-6-def.T.notable_fbp1_pathogeni/?report=objectonly" target="object" rid-figpopup="figfructose16defTnotablefbp1pathogeni" rid-ob="figobfructose16defTnotablefbp1pathogeni">Table 7</a>. Given the rarity of fructose-1-6-bisphosphatase deficiency, the efficacy of targeted testing for specific pathogenic variants in individuals of these ancestries is not known.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> (such as one for hypoglycemia or lactic acidosis) that includes <i>FBP1</i> and other genes of interest (see <a href="#fructose1-6-def.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. Of note, given the rarity of fructose-1,6-bisphosphatase deficiency, some panels may not include <i>FBP1</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests. For this disorder a multigene panel that also includes deletion/duplication analysis is recommended (see <a class="figpopup" href="/books/NBK550349/table/fructose1-6-def.T.molecular_genetic_test/?report=objectonly" target="object" rid-figpopup="figfructose16defTmoleculargenetictest" rid-ob="figobfructose16defTmoleculargenetictest">Table 1</a>).</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul><div id="fructose1-6-def.T.molecular_genetic_test" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Fructose-1,6-Bisphosphatase Deficiency</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK550349/table/fructose1-6-def.T.molecular_genetic_test/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__fructose1-6-def.T.molecular_genetic_test_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_fructose1-6-def.T.molecular_genetic_test_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_fructose1-6-def.T.molecular_genetic_test_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_fructose1-6-def.T.molecular_genetic_test_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_fructose1-6-def.T.molecular_genetic_test_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>FBP1</i></td><td headers="hd_h_fructose1-6-def.T.molecular_genetic_test_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_fructose1-6-def.T.molecular_genetic_test_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~90%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_fructose1-6-def.T.molecular_genetic_test_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_fructose1-6-def.T.molecular_genetic_test_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~10%&#x000a0;<sup>6</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="fructose1-6-def.TF.1.1"><p class="no_margin">See <a href="/books/NBK550349/#fructose1-6-def.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="fructose1-6-def.TF.1.2"><p class="no_margin">See <a href="#fructose1-6-def.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="fructose1-6-def.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="fructose1-6-def.TF.1.4"><p class="no_margin"><a class="bk_pop" href="#fructose1-6-def.REF.kikawa.1997.852">Kikawa et al [1997]</a>, <a class="bk_pop" href="#fructose1-6-def.REF.prahl.2006.4014">Prahl et al [2006]</a>, <a class="bk_pop" href="#fructose1-6-def.REF.afroze.2013.1249">Afroze et al [2013]</a>, <a class="bk_pop" href="#fructose1-6-def.REF.takagi.2013.761">Takagi et al [2013]</a>, <a class="bk_pop" href="#fructose1-6-def.REF.lebigot.2015.881">Lebigot et al [2015]</a>, <a class="bk_pop" href="#fructose1-6-def.REF.santer.2016.44">Santer et al [2016]</a>, <a class="bk_pop" href="#fructose1-6-def.REF.ijaz.2017.1203">Ijaz et al [2017]</a>, <a class="bk_pop" href="#fructose1-6-def.REF.bhai.2018.309">Bhai et al [2018]</a>, <a class="bk_pop" href="#fructose1-6-def.REF.moey.2018.397">Moey et al [2018]</a>, <a class="bk_pop" href="#fructose1-6-def.REF.pinheiro.2019.102">Pinheiro et al [2019]</a></p></div></dd><dt>5. </dt><dd><div id="fructose1-6-def.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="fructose1-6-def.TF.1.6"><p class="no_margin"><a class="bk_pop" href="#fructose1-6-def.REF.herzog.2001.87">Herzog et al [2001]</a>, <a class="bk_pop" href="#fructose1-6-def.REF._sberg.2010.s113">&#x000c5;sberg et al [2010]</a>, <a class="bk_pop" href="#fructose1-6-def.REF.lebigot.2015.881">Lebigot et al [2015]</a>, <a class="bk_pop" href="#fructose1-6-def.REF.santer.2016.44">Santer et al [2016]</a>, <a class="bk_pop" href="#fructose1-6-def.REF.bhai.2018.309">Bhai et al [2018]</a></p></div></dd></dl></div></div></div></div><div id="fructose1-6-def.Analysis_of_Fructose1_6B"><h4>Analysis of Fructose-1,6-Bisphosphatase (FBP1 or FBPase) Activity</h4><p>While enzymatic activity in leukocytes and liver is very specific, testing is not widely available [<a class="bk_pop" href="#fructose1-6-def.REF.besley.1994.333">Besley et al 1994</a>, <a class="bk_pop" href="#fructose1-6-def.REF.lebigot.2015.881">Lebigot et al 2015</a>]: spectrophotometric analysis to estimate enzyme activity in leukocytes is performed in a few laboratories worldwide. The usual assay tests FBP1 activity by measuring the amount of NADPH formed &#x02013; a nonspecific assay as NADPH may be formed from other reactions within the cells. Specificity can be achieved by testing for FBP1 activity in the presence and absence of AMP, a specific inhibitor for the enzyme [<a class="bk_pop" href="#fructose1-6-def.REF.lebigot.2015.881">Lebigot et al 2015</a>]. FBP1 stability in untreated blood samples at +4 &#x000b0;C lasts 24 hours, and therefore samples can be transported long distances to a reference laboratory.</p></div></div></div><div id="fructose1-6-def.Clinical_Characteristics"><h2 id="_fructose1-6-def_Clinical_Characteristics_">Clinical Characteristics</h2><div id="fructose1-6-def.Clinical_Description"><h3>Clinical Description</h3><p>The manifestations of fructose-1,6-bisphosphatase (FBP1) deficiency are generally episodic due to lactic acidosis and ketotic hypoglycemia, which are often triggered by fasting or febrile infections. The episodes of acute crisis are most frequent in early life &#x02013; neonatal period, infancy, and early childhood &#x02013; and subsequently decrease in frequency. In FBP1 deficiency, several metabolic derangements can occur with or without hypoglycemia.</p><p>Classically, FBP1 deficiency manifests in the first year of life. Nearly half of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> infants present within the first four days of life with an acute crisis. Neonatal presentation results from hypoglycemia due to deficient glycogen stores [<a class="bk_pop" href="#fructose1-6-def.REF.steinmann.2016">Steinmann &#x00026; Santer 2016</a>].</p><p>Acute crises are characterized by episodes of hyperventilation, apneic spells, seizures, and/or coma, often with hepatomegaly. Muscular hypotonia may also be present. This may be associated with transient liver dysfunction (transaminitis), which does not require specific treatment [<a class="bk_pop" href="#fructose1-6-def.REF.bhai.2018.309">Bhai et al 2018</a>]. With age, the frequency of attacks decreases and episodes are characterized by irritability, somnolence, hypotonia, and dyspnea.</p><p>Factors known to trigger episodes include fever, fasting, decreased oral intake, vomiting, infections, and ingestion of large amounts of fructose. Episodes tend to be recurrent. Often four to five episodes occur before the correct diagnosis is established [<a class="bk_pop" href="#fructose1-6-def.REF.lebigot.2015.881">Lebigot et al 2015</a>].</p><p>In between crises, children are asymptomatic and the majority experience normal growth and psychomotor development [<a class="bk_pop" href="#fructose1-6-def.REF.steinmann.2016">Steinmann &#x00026; Santer 2016</a>]. A few children with brain injury and/or intellectual disability have been reported, probably related to early and prolonged hypoglycemia [<a class="bk_pop" href="#fructose1-6-def.REF.li.2017.e857">Li et al 2017</a>, <a class="bk_pop" href="#fructose1-6-def.REF.moey.2018.397">Moey et al 2018</a>].</p><p>In untreated individuals, symptoms worsen progressively as continued catabolism leads to multiorgan failure (especially liver, brain, and later heart). Morbidity and mortality are high. Sepsis, blindness, and Reye syndrome-like presentation have been reported [<a class="bk_pop" href="#fructose1-6-def.REF.lebigot.2015.881">Lebigot et al 2015</a>, <a class="bk_pop" href="#fructose1-6-def.REF.bhai.2018.309">Bhai et al 2018</a>].</p></div><div id="fructose1-6-def.GenotypePhenotype_Correl"><h3>Genotype-Phenotype Correlations</h3><p>No <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> have been identified.</p></div><div id="fructose1-6-def.Nomenclature"><h3>Nomenclature</h3><p><a class="bk_pop" href="#fructose1-6-def.REF.baker.1970.13">Baker &#x00026; Winegrad [1970]</a> first described deficiency of hepatic fructose-1,6-bisphosphatase 1 (hence the eponymous Baker-Winegrad disease) in a child with hypoglycemia and metabolic acidosis on fasting.</p></div><div id="fructose1-6-def.Prevalence"><h3>Prevalence</h3><p>Fructose-1,6-bisphosphatase deficiency is rare. Approximately 150 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have been reported to date.</p><p>An estimated prevalence of fructose-1,6-bisphosphatase deficiency is 1:350,000 in the Dutch population [<a class="bk_pop" href="#fructose1-6-def.REF.visser.2004.207">Visser et al 2004</a>] and &#x0003c;1:900,000 in the French population [<a class="bk_pop" href="#fructose1-6-def.REF.lebigot.2015.881">Lebigot et al 2015</a>]. The disorder may be more frequent in populations with higher rates of <a class="def" href="/books/n/gene/glossary/def-item/consanguinity/">consanguinity</a> [<a class="bk_pop" href="#fructose1-6-def.REF.santer.2016.44">Santer et al 2016</a>].</p></div></div><div id="fructose1-6-def.Genetically_Related_Alle"><h2 id="_fructose1-6-def_Genetically_Related_Alle_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants in <i>FBP1</i>.</p></div><div id="fructose1-6-def.Differential_Diagnosis"><h2 id="_fructose1-6-def_Differential_Diagnosis_">Differential Diagnosis</h2><p><a class="figpopup" href="/books/NBK550349/table/fructose1-6-def.T.disorders_and_associat/?report=objectonly" target="object" rid-figpopup="figfructose16defTdisordersandassociat" rid-ob="figobfructose16defTdisordersandassociat">Table 2a</a> provides a comparative analysis of disorders with clinical similarities to fructose-1,6-bisphosphatase (FBP1) deficiency. <a class="figpopup" href="/books/NBK550349/table/fructose1-6-def.T.biochemical_parameters/?report=objectonly" target="object" rid-figpopup="figfructose16defTbiochemicalparameters" rid-ob="figobfructose16defTbiochemicalparameters">Table 2b</a> compares the biochemical parameters of these disorders.</p><p>Information on mitochondrial respiratory chain and Krebs cycle disorders and fatty acid oxidation defects follows <a class="figpopup" href="/books/NBK550349/table/fructose1-6-def.T.biochemical_parameters/?report=objectonly" target="object" rid-figpopup="figfructose16defTbiochemicalparameters" rid-ob="figobfructose16defTbiochemicalparameters">Table 2b</a>.</p><div id="fructose1-6-def.T.disorders_and_associat" class="table"><h3><span class="label">Table 2a. </span></h3><div class="caption"><p>Disorders (and Associated Genes) of Interest in the Differential Diagnosis of Fructose-1,6-Bisphosphatase Deficiency</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK550349/table/fructose1-6-def.T.disorders_and_associat/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__fructose1-6-def.T.disorders_and_associat_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_fructose1-6-def.T.disorders_and_associat_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_fructose1-6-def.T.disorders_and_associat_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Disorder&#x000a0;<sup>1</sup></th><th id="hd_h_fructose1-6-def.T.disorders_and_associat_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Differential Diagnosis Disorder: Features Overlapping w/FBP1 Deficiency</th><th id="hd_h_fructose1-6-def.T.disorders_and_associat_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing Between FBP1 Deficiency &#x00026; Differential Diagnosis Disorder</th></tr></thead><tbody><tr><td headers="hd_h_fructose1-6-def.T.disorders_and_associat_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ACAT1</i></td><td headers="hd_h_fructose1-6-def.T.disorders_and_associat_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Beta-ketothiolase deficiency<br />(OMIM <a href="https://omim.org/entry/203750" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">203750</a>)</td><td headers="hd_h_fructose1-6-def.T.disorders_and_associat_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ketolytic defect characterized by ketotic hypoglycemia or hyperglycemia &#x00026; metabolic acidosis</td><td headers="hd_h_fructose1-6-def.T.disorders_and_associat_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In BKD: &#x02191; of specific metabolites on urine organic acids by GCMS can include 2-methylacetocetate, 2-methyl-3-hydroxybutyryl CoA, &#x00026; tiglylglycine.</td></tr><tr><td headers="hd_h_fructose1-6-def.T.disorders_and_associat_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ALDOB</i></td><td headers="hd_h_fructose1-6-def.T.disorders_and_associat_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/hfi/">Hereditary fructose intolerance</a>&#x000a0;<sup>2</sup></td><td headers="hd_h_fructose1-6-def.T.disorders_and_associat_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>When weaned onto sucrose- or fructose-containing foods, infants can manifest nausea, bloating, vomiting, sweating, abdominal pain, &#x00026; growth restriction.</div></li><li class="half_rhythm"><div>Chronic liver &#x00026; renal disease occur in untreated children.</div></li></ul>
</td><td headers="hd_h_fructose1-6-def.T.disorders_and_associat_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Overall, HFI has a more chronic course than FBP1D.</div></li><li class="half_rhythm"><div>Children w/HFI have strong aversion to sweets &#x00026; often have renal tubular dysfunction, (not seen in FBP1D).</div></li><li class="half_rhythm"><div>Children w/FBP1D do not have GI symptoms or FTT w/chronic fructose ingestion.</div></li></ul>
</td></tr><tr><td headers="hd_h_fructose1-6-def.T.disorders_and_associat_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>G6PC</i><br /><i>SLC37A4</i></td><td headers="hd_h_fructose1-6-def.T.disorders_and_associat_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/gsd1/">Glycogen storage disease type I</a>&#x000a0;<sup>3</sup></td><td headers="hd_h_fructose1-6-def.T.disorders_and_associat_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Accumulation of glycogen &#x00026; fat in liver &#x00026; kidneys, resulting in hepatomegaly &#x00026; renomegaly</div></li><li class="half_rhythm"><div>Untreated infants present at age 3-4 mos w/hepatomegaly, lactic acidosis, hyperuricemia, hyperlipidemia, hypertriglyceridemia, &#x00026;/or hypoglycemic seizures.</div></li></ul>
</td><td headers="hd_h_fructose1-6-def.T.disorders_and_associat_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Detection of glycerol in FBP1D (on urine organic acid analysis) is useful in differentiating the disorders.</td></tr><tr><td headers="hd_h_fructose1-6-def.T.disorders_and_associat_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PC</i></td><td headers="hd_h_fructose1-6-def.T.disorders_and_associat_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/pdc/">Pyruvate carboxylase deficiency</a>&#x000a0;<sup>4</sup></td><td headers="hd_h_fructose1-6-def.T.disorders_and_associat_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Episodes of acute vomiting, tachypnea, &#x00026; acidosis are usually precipitated by metabolic stress or infection; episodes may be very similar to FBP1D (w/&#x02191; lactate-to-pyruvate ratio, hyperalaninemia, hypoglycemia, &#x00026; metabolic acidosis).</td><td headers="hd_h_fructose1-6-def.T.disorders_and_associat_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">The neurologic involvement, severe ID, &#x00026; recurrent seizures characteristic of PCD types A &#x00026; B are not observed in FBP1D.</td></tr><tr><td headers="hd_h_fructose1-6-def.T.disorders_and_associat_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PGM1</i></td><td headers="hd_h_fructose1-6-def.T.disorders_and_associat_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">PGM1-CDG<br />(see <a href="/books/n/gene/cdg/">Congenital Disorders of N-Linked Glycosylation and Multiple Pathway Overview</a>)</td><td headers="hd_h_fructose1-6-def.T.disorders_and_associat_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Presents more commonly w/rhabdomyolysis; however, episodic hypoglycemia &#x00026; metabolic acidosis may also occur.</td><td headers="hd_h_fructose1-6-def.T.disorders_and_associat_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Short stature, birth defects (incl cleft palate, bifid uvula), &#x00026; dilated cardiomyopathy may be present in PGM1-CDG.</div></li><li class="half_rhythm"><div>Transferrin <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> are abnormal &#x00026; aid in diagnosis of PGM1-CDG.</div></li></ul>
</td></tr><tr><td headers="hd_h_fructose1-6-def.T.disorders_and_associat_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Multiple</td><td headers="hd_h_fructose1-6-def.T.disorders_and_associat_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Fatty acid oxidation<br />defects (FAODs)</td><td headers="hd_h_fructose1-6-def.T.disorders_and_associat_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">FAODs can present in neonates w/hypoglycemia, hyperammonemia, &#x00026; &#x02193;/absent ketones.</td><td headers="hd_h_fructose1-6-def.T.disorders_and_associat_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Typically hypoketotic hypoglycemia</div></li><li class="half_rhythm"><div>&#x02191; acylcarnitine in MS/MS</div></li></ul>
</td></tr><tr><td headers="hd_h_fructose1-6-def.T.disorders_and_associat_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Multiple</td><td headers="hd_h_fructose1-6-def.T.disorders_and_associat_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mitochondrial respiratory chain disorders &#x00026; Krebs cycle disorders</td><td headers="hd_h_fructose1-6-def.T.disorders_and_associat_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Multisystem involvement in which the most metabolically active organs are most affected (e.g., brain, liver, kidney, heart)</td><td headers="hd_h_fructose1-6-def.T.disorders_and_associat_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mitochondrial disorders have a more chronic course than FBP1D.</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">BKD = beta-ketothiolase deficiency; CDG = <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> disorder of glycosylation; FBP1D = FBP1 deficiency; FTT = failure to thrive; HFI = hereditary fructose intolerance; ID = intellectual disability; MS/MS = tandem mass spectrometry; PCD = pyruvate carboxylase deficiency</p></div></dd><dt>1. </dt><dd><div id="fructose1-6-def.TF.2a.1"><p class="no_margin">Disorders included in this table are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner with the exception of mitochondrial respiratory chain and Krebs cycle disorders, which may be inherited in an autosomal recessive manner, an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner, or by maternal inheritance.</p></div></dd><dt>2. </dt><dd><div id="fructose1-6-def.TF.2a.2"><p class="no_margin">Hereditary fructose intolerance is due to deficiency of enzyme aldolase B, which facilitates the breakdown of fructose-1-phosphate into dihydroxyacetone phosphate and glyceraldehyde.</p></div></dd><dt>3. </dt><dd><div id="fructose1-6-def.TF.2a.3"><p class="no_margin">GSDI is due to the deficiency of enzyme glucose-6-phosphatase.</p></div></dd><dt>4. </dt><dd><div id="fructose1-6-def.TF.2a.4"><p class="no_margin">Pyruvate carboxylase enzyme aids in the irreversible carboxylation of pyruvate to oxaloacetate.</p></div></dd></dl></div></div></div><div id="fructose1-6-def.T.biochemical_parameters" class="table"><h3><span class="label">Table 2b. </span></h3><div class="caption"><p>Biochemical Parameters of Disorders in the Differential Diagnosis of Fructose-1,6-Bisphosphatase Deficiency</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK550349/table/fructose1-6-def.T.biochemical_parameters/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__fructose1-6-def.T.biochemical_parameters_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Biochemical Parameter</th><th id="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">FBP1</th><th id="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">BKT</th><th id="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">HFI</th><th id="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">GSDI</th><th id="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_6" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">PCD</th><th id="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_7" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">FAOD</th><th id="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_8" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Respiratory<br />Chain Defects</th></tr></thead><tbody><tr><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02191; lactate</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Fasting</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">During crisis</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Fasting</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Permanent, also increased w/fasting</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Permanent</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Fasting</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Permanent</td></tr><tr><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Lactate/<br />pyruvate ratio</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">20-40</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02013;</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02013;</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02013;</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;30</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02013;</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;20</td></tr><tr><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ketosis</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>&#x02191;&#x02191;</b>/&#x02013;</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>&#x02191;&#x02191;</b></td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>&#x02191;</b></td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>&#x02191;&#x02191;</b>/&#x02013;</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>&#x02191;&#x02191;&#x02191;</b></td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02013;</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>&#x02191;&#x02191;</b></td></tr><tr><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Triglycerides</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pseudo-<br />hyper</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>&#x02191;</b></td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>&#x02191;</b></td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N</td></tr><tr><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Glucose</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">L</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">L</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">L</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N/L</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">L/N/H</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N/L</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">L</td></tr><tr><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ammonia</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>&#x02191;</b></td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>&#x02191;&#x02191;</b></td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>&#x02191;</b></td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N/<b>&#x02191;&#x02191;</b></td></tr><tr><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Alanine</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>&#x02191;&#x02191;</b></td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>&#x02191;&#x02191;</b></td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>&#x02191;&#x02191;</b></td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>&#x02191;&#x02191;</b></td></tr><tr><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Citrulline</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">H</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N</td></tr><tr><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Liver dysfunction (transaminitis)</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>&#x02191;</b>/&#x02013;</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>&#x02191;</b></td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>&#x02191;</b></td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>&#x02191;</b></td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>&#x02191;</b></td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>&#x02191;</b>/&#x02013;</td></tr><tr><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Uric acid</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>&#x02191;</b></td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>&#x02191;</b></td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N</td></tr><tr><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Organic acids in urine</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ketonuria, glycerol, glycerol-3-phosphate</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2-methylacetocetate, 2-methyl-3-hydroxybutyryl CoA, tiglylglycine</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ketonuria</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ketonuria</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Lactate/<br />ketonuria</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02191; C16-C22</td><td headers="hd_h_fructose1-6-def.T.biochemical_parameters_1_1_1_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Lactate</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin"><b>&#x02191;</b> = increased; <b>&#x02191;&#x02191;</b> = moderately increased; <b>&#x02191;&#x02191;&#x02191;</b> = severely increased; BKT = beta-ketothiolase deficiency; FAOD = fatty acid oxidation defect; GSDI = glycogen storage disease type 1; H = high; HFI = hereditary fructose intolerance; L = low; N = normal; PCD = pyruvate carboxylase deficiency</p></div></dd></dl></div></div></div><p><b>Fatty acid oxidation defects (FAODs)</b> are mitochondrial disorders caused by defective beta-oxidation of fatty acids. FAODs can present in neonates with hypoglycemia, hyperammonemia, and reduced/absent ketones. As ketones could be normal in FBP1 deficiency, diagnosis of FAOD is based on elevated acylcarnitine profiles on MS/MS.</p><p><b>Mitochondrial respiratory chain and Krebs cycle disorders.</b> Mitochondrial respiratory chain disorders are a heterogeneous group of disorders that share involvement of the cellular bioenergetic machinery due to molecular defects affecting the mitochondrial oxidative phosphorylation system. The variable presentation can include neonatal metabolic acidosis with increased lactate. The usual disease course is a gradually progressive loss of developmental milestones; however, more rapid decline occurs with episodic crises. Urine organic acid profile may reveal distinctive elevation of fumaric acid or other Krebs cycle intermediates, reflecting the site of the enzyme deficiency. See <a href="/books/n/gene/mt-overview/">Mitochondrial Disorders Overview</a>.</p></div><div id="fructose1-6-def.Management"><h2 id="_fructose1-6-def_Management_">Management</h2><div id="fructose1-6-def.Evaluations_Following_In"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in a child diagnosed with fructose-1,6-bisphosphatase (FBP1) deficiency who is not in acute crisis, the evaluations summarized in <a class="figpopup" href="/books/NBK550349/table/fructose1-6-def.T.recommended_evaluation/?report=objectonly" target="object" rid-figpopup="figfructose16defTrecommendedevaluation" rid-ob="figobfructose16defTrecommendedevaluation">Table 3</a> (if not performed as part of the evaluation that led to the diagnosis) are recommended [<a class="bk_pop" href="#fructose1-6-def.REF.wang.2017.7273">Wang et al 2017</a>, <a class="bk_pop" href="#fructose1-6-def.REF.bhai.2018.309">Bhai et al 2018</a>].</p><p>Note that the management of possible multisystem complications resulting from early and prolonged hypoglycemia are not discussed in this <i>GeneReview</i>.</p><div id="fructose1-6-def.T.recommended_evaluation" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Recommended Evaluations Following Initial Diagnosis of Fructose-1,6-Bisphosphatase Deficiency for a Child Not in Acute Crisis</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK550349/table/fructose1-6-def.T.recommended_evaluation/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__fructose1-6-def.T.recommended_evaluation_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_fructose1-6-def.T.recommended_evaluation_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation/Concern</th><th id="hd_h_fructose1-6-def.T.recommended_evaluation_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment</th></tr></thead><tbody><tr><td headers="hd_h_fructose1-6-def.T.recommended_evaluation_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consultation w/metabolic physician / biochemical geneticist &#x00026; specialist metabolic dietician</td><td headers="hd_h_fructose1-6-def.T.recommended_evaluation_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Consider obtaining baseline blood gas, lactate, ketones, CK.&#x000a0;<sup>1</sup></div></li><li class="half_rhythm"><div>Assess growth parameters (height, weight, head circumference).</div></li><li class="half_rhythm"><div>Assess diet &#x00026; nutritional status.</div></li></ul>
</td></tr><tr><td headers="hd_h_fructose1-6-def.T.recommended_evaluation_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hepatomegaly</td><td headers="hd_h_fructose1-6-def.T.recommended_evaluation_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Abdominal ultrasound to assess for hepatomegaly</div></li><li class="half_rhythm"><div>Baseline liver function tests</div></li><li class="half_rhythm"><div>Baseline serum lipid panel&#x000a0;<sup>2</sup></div></li><li class="half_rhythm"><div>Baseline serum uric acid</div></li></ul>
</td></tr><tr><td headers="hd_h_fructose1-6-def.T.recommended_evaluation_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Developmental assessment</td><td headers="hd_h_fructose1-6-def.T.recommended_evaluation_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Referral to developmental pediatrician to assess motor, adaptive, cognitive, &#x00026; speech/language skills; need for early intervention / special education</td></tr><tr><td headers="hd_h_fructose1-6-def.T.recommended_evaluation_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consultation w/clinical geneticist &#x00026;/or genetic counselor</td><td headers="hd_h_fructose1-6-def.T.recommended_evaluation_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Incl <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a></td></tr><tr><td headers="hd_h_fructose1-6-def.T.recommended_evaluation_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Family support/resources</td><td headers="hd_h_fructose1-6-def.T.recommended_evaluation_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assess:
<ul><li class="half_rhythm"><div>Use of community or online resources such as Parent to Parent;</div></li><li class="half_rhythm"><div>Need for social work involvement for parental support.</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="fructose1-6-def.TF.3.1"><p class="no_margin">Elevation of CK has been noted in at least one individual in acute crisis [<a class="bk_pop" href="#fructose1-6-def.REF.bhai.2018.309">Bhai et al 2018</a>]. This may indicate rhabdomyolysis secondary to energy deficiency.</p></div></dd><dt>2. </dt><dd><div id="fructose1-6-def.TF.3.2"><p class="no_margin">See pseudo-hypertriglyceridemia in <a href="#fructose1-6-def.Suggestive_Findings">Suggestive Findings</a>.</p></div></dd></dl></div></div></div></div><div id="fructose1-6-def.Treatment_of_Manifestati"><h3>Treatment of Manifestations</h3><p>An international survey of 126 patients from 36 centers revealed widely varying practices of fructose/sucrose restriction; the authors concluded that internationally accepted guidelines for management and surveillance were needed [<a class="bk_pop" href="#fructose1-6-def.REF.pinto.2018.21">Pinto et al 2018</a>].</p><p><b>Management of acute crises.</b> Acute crises are more frequent in early life &#x02013; neonatal period, infancy, and early childhood &#x02013; with gradual decrease afterwards.</p><p>Intervention (oral glucose or IV dextrose) should take place early in an acute crisis while the blood glucose is normal due to the possibility of delayed hypoglycemia, which only occurs relatively late in the course of acute metabolic decompensation.</p><p>The family must be given the contact information for an expert metabolic center and a clear emergency outpatient treatment plan during illness (<a class="figpopup" href="/books/NBK550349/table/fructose1-6-def.T.emergency_outpatient_t/?report=objectonly" target="object" rid-figpopup="figfructose16defTemergencyoutpatientt" rid-ob="figobfructose16defTemergencyoutpatientt">Table 4</a>) and emergency letters/cards with information on principles of acute in-patient treatment (<a class="figpopup" href="/books/NBK550349/table/fructose1-6-def.T.acute_inpatient_treatm/?report=objectonly" target="object" rid-figpopup="figfructose16defTacuteinpatienttreatm" rid-ob="figobfructose16defTacuteinpatienttreatm">Table 5</a>).</p><p><b>Emergency outpatient treatment.</b> The threshold for emergency outpatient evaluation and treatment should be low. Acute management guidelines are available from the <a href="http://www.bimdg.org.uk/site/guidelines.asp" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">British Inherited Metabolic Disease Group</a>. See <a href="http://www.bimdg.org.uk/store/guidelines/ER-f16bisP-v4_567327_09092016.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">protocol</a> (pdf).</p><p>Laboratory evaluations during acute illnesses should include pH and blood gases, glucose (laboratory and bedside strip test), urea and electrolytes, complete blood count, lactate, blood culture, and urine ketones.</p><p>The child should receive emergency treatment if he/she is vomiting, complaining of stomach pain, or not wanting to eat or drink, irrespective of associated symptoms (e.g., fever, cough, cold).</p><div id="fructose1-6-def.T.emergency_outpatient_t" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Emergency Outpatient Treatment in Individuals with Fructose-1,6-Bisphosphatase Deficiency</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK550349/table/fructose1-6-def.T.emergency_outpatient_t/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__fructose1-6-def.T.emergency_outpatient_t_lrgtbl__"><table><thead><tr><th id="hd_h_fructose1-6-def.T.emergency_outpatient_t_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Manifestation/<br />Concern</th><th id="hd_h_fructose1-6-def.T.emergency_outpatient_t_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treatment</th><th id="hd_h_fructose1-6-def.T.emergency_outpatient_t_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Considerations</th></tr></thead><tbody><tr><td headers="hd_h_fructose1-6-def.T.emergency_outpatient_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Mildly &#x02191; catabolism</b><br /><b>(fever, cough, or</b><br /><b>cold; loose stools;</b><br /><b>continues to eat;</b><br /><b>not assoc w/lethargy)</b></td><td headers="hd_h_fructose1-6-def.T.emergency_outpatient_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><dl class="temp-labeled-list"><dt>1.</dt><dd><p class="no_top_margin">Restriction of fructose, sucrose, glycerol, &#x00026; sorbitol</p></dd><dt>2.</dt><dd><p class="no_top_margin">&#x02191; frequency of carbohydrate feedings</p></dd><dt>3.</dt><dd><p class="no_top_margin">Intake of glucose polymers</p></dd></dl>
</td><td headers="hd_h_fructose1-6-def.T.emergency_outpatient_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Trial of outpatient treatment at home requires good communication between family &#x00026; providers.</div></li><li class="half_rhythm"><div>Frequent reassessment of patient</div></li></ul>
</td></tr><tr><td headers="hd_h_fructose1-6-def.T.emergency_outpatient_t_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Ketonuria</b></td><td headers="hd_h_fructose1-6-def.T.emergency_outpatient_t_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_fructose1-6-def.T.emergency_outpatient_t_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">An early indicator of impending crisis</td></tr></tbody></table></div></div><p><b>Acute in-patient treatment.</b> Acute manifestations of hypoglycemia (lethargy, encephalopathy, seizures, hyperhidrosis), often occurring in the setting of intercurrent illness and/or inadequate caloric intake, should be managed symptomatically and with generous caloric support in a hospital setting, with aggressive treatment and supportive care of any identified or clinically suspected acute conditions.</p><div id="fructose1-6-def.T.acute_inpatient_treatm" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p>Acute In-Patient Treatment in Individuals with Fructose-1,6-Bisphosphatase Deficiency</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK550349/table/fructose1-6-def.T.acute_inpatient_treatm/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__fructose1-6-def.T.acute_inpatient_treatm_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_fructose1-6-def.T.acute_inpatient_treatm_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Manifestation/<br />Concern</th><th id="hd_h_fructose1-6-def.T.acute_inpatient_treatm_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treatment</th><th id="hd_h_fructose1-6-def.T.acute_inpatient_treatm_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Considerations</th></tr></thead><tbody><tr><td headers="hd_h_fructose1-6-def.T.acute_inpatient_treatm_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hypoglycemia</b></td><td headers="hd_h_fructose1-6-def.T.acute_inpatient_treatm_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><dl class="temp-labeled-list"><dt>1.</dt><dd><p class="no_top_margin">IV glucose bolus (2 mL/kg of 10% dextrose) followed by continuous infusion of glucose at high rates (10% dextrose infusion)</p></dd><dt>2.</dt><dd><p class="no_top_margin">Transition to oral/enteral feeds as clinically tolerated</p></dd></dl>
</td><td headers="hd_h_fructose1-6-def.T.acute_inpatient_treatm_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">The symptoms of acute illness typically subside soon after administration of IV dextrose &#x00026; child should recover quickly (w/in hrs), usually w/no residual damage.</td></tr><tr><td headers="hd_h_fructose1-6-def.T.acute_inpatient_treatm_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Metabolic acidosis</b></td><td headers="hd_h_fructose1-6-def.T.acute_inpatient_treatm_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><dl class="temp-labeled-list"><dt>1.</dt><dd><p class="no_top_margin">IV glucose bolus as above</p></dd><dt>2.</dt><dd><p class="no_top_margin">If pH remains &#x0003c;7.1 or worsens, administer NaHCO<sub>3</sub> as 1/2 the calculated dose over a 30-min period.</p></dd><dt>3.</dt><dd><p class="no_top_margin">Restrict fructose, glycerol, sucrose, &#x00026; sorbitol.</p></dd></dl>
</td><td headers="hd_h_fructose1-6-def.T.acute_inpatient_treatm_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Acidosis usually corrects quickly w/out NaHCO<sub>3</sub> infusion.</div></li><li class="half_rhythm"><div>No consensus exists re restriction of dietary fructose &#x00026; sucrose.</div></li></ul>
</td></tr><tr><td headers="hd_h_fructose1-6-def.T.acute_inpatient_treatm_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hepatomegaly &#x00026; &#x02191; transaminases</b></td><td headers="hd_h_fructose1-6-def.T.acute_inpatient_treatm_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None</td><td headers="hd_h_fructose1-6-def.T.acute_inpatient_treatm_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Transient findings that resolve spontaneously</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">IV = intravenous; NaHCO<sub>3</sub> = sodium bicarbonate</p></div></dd></dl></div></div></div></div><div id="fructose1-6-def.Prevention_of_Primary_Ma"><h3>Prevention of Primary Manifestations</h3><p>The main principles of routine daily management are the following:</p><ul><li class="half_rhythm"><div>Prevention of hypoglycemia (by avoiding fasting and consuming frequent meals). Slowly absorbed carbohydrates such as uncooked cornstarch (1-2 g/kg) mixed in milk or water at bedtime may be introduced to children after age six to 12 months who have nocturnal hypoglycemia [<a class="bk_pop" href="#fructose1-6-def.REF.pinto.2018.21">Pinto et al 2018</a>].</div></li><li class="half_rhythm"><div>Appropriate management of acute intercurrent illnesses, which can exacerbate the need for glucose</div></li><li class="half_rhythm"><div>Restriction of food items or medicines that contain fructose, sucrose, glycerol, and/or sorbitol</div></li></ul><p>Also advised are routine immunizations, including annual influenza vaccine, to reduce the risk of infections that can precipitate hypoglycemia.</p></div><div id="fructose1-6-def.Surveillance"><h3>Surveillance</h3><p>No formal guidelines for long-term surveillance for individuals with FBP1 deficiency exist. <a class="figpopup" href="/books/NBK550349/table/fructose1-6-def.T.recommended_longterm_s/?report=objectonly" target="object" rid-figpopup="figfructose16defTrecommendedlongterms" rid-ob="figobfructose16defTrecommendedlongterms">Table 6</a> summarizes long-term surveillance based on the natural history of the disorder.</p><div id="fructose1-6-def.T.recommended_longterm_s" class="table"><h3><span class="label">Table 6. </span></h3><div class="caption"><p>Recommended Long-Term Surveillance for Individuals with Fructose-1,6-Bisphosphatase Deficiency</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK550349/table/fructose1-6-def.T.recommended_longterm_s/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__fructose1-6-def.T.recommended_longterm_s_lrgtbl__"><table><thead><tr><th id="hd_h_fructose1-6-def.T.recommended_longterm_s_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Manifestation/<br />Concern</th><th id="hd_h_fructose1-6-def.T.recommended_longterm_s_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_fructose1-6-def.T.recommended_longterm_s_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequency/Comment</th></tr></thead><tbody><tr><td headers="hd_h_fructose1-6-def.T.recommended_longterm_s_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Delayed acquisition of developmental milestones</b></td><td headers="hd_h_fructose1-6-def.T.recommended_longterm_s_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Monitor developmental milestones.</td><td headers="hd_h_fructose1-6-def.T.recommended_longterm_s_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">At each visit</td></tr><tr><td headers="hd_h_fructose1-6-def.T.recommended_longterm_s_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Neuropsychological testing using age-appropriate standardized assessment batteries</td><td headers="hd_h_fructose1-6-def.T.recommended_longterm_s_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">As needed</td></tr><tr><td headers="hd_h_fructose1-6-def.T.recommended_longterm_s_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Standardized quality-of-life assessment tools for <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals &#x00026; parents/caregivers</td><td headers="hd_h_fructose1-6-def.T.recommended_longterm_s_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">As needed</td></tr><tr><td headers="hd_h_fructose1-6-def.T.recommended_longterm_s_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Excessive weight gain</b></td><td headers="hd_h_fructose1-6-def.T.recommended_longterm_s_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Measurement of growth, weight, &#x00026; head circumference</td><td headers="hd_h_fructose1-6-def.T.recommended_longterm_s_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">At each visit</td></tr></tbody></table></div></div></div><div id="fructose1-6-def.AgentsCircumstances_to_A"><h3>Agents/Circumstances to Avoid</h3><p>Avoid ingestion of food items or medicines that contain fructose, sucrose, glycerol, and/or sorbitol, especially during acute crises in infancy or early childhood.</p><p>Although small amounts of fructose (&#x02264;2 g/kg/day) are well tolerated by patients with FBP1 deficiency, single ingestion of high doses of fructose (&#x0003e;1g/kg) is harmful, especially in younger children.</p><p>The fructose tolerance testing ("fructose challenge") to diagnose FBP1 deficiency can be hazardous and should not be performed.</p></div><div id="fructose1-6-def.Evaluation_of_Relatives"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to clarify the status of apparently asymptomatic older and younger at-risk sibs of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual in order to identify as early as possible those who would benefit from prompt initiation of measures to prevent acute crises (frequent feedings and avoidance of fasting) and prompt treatment of infections / febrile illnesses. Evaluations should include targeted <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> if the <i>FBP1</i> pathogenic variants in the family are known.</p><p>For newborns who may be at risk for FBP1 deficiency, it is important to avoid fasting, to feed regularly, and to monitor for hypoglycemia and acidosis while awaiting results of biochemical and/or <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>. Monitoring for hypoglycemia can include use of bedside glucometers and clinical monitoring for lethargy, poor intake, vomiting, hypothermia, and/or tachypnea. A low threshold for starting an intravenous infusion of 5%-10% dextrose may help prevent triggering of an acute crisis, especially in newborns who have low birth weight, are preterm, or have a diabetic mother.</p><p>See <a href="#fructose1-6-def.Related_Genetic_Counseli">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="fructose1-6-def.Pregnancy_Management"><h3>Pregnancy Management</h3><p>Although successful pregnancies have been reported in women with FBP1 deficiency [<a class="bk_pop" href="#fructose1-6-def.REF._sberg.2010.s113">&#x000c5;sberg et al 2010</a>], certain precautions should be taken:</p><ul><li class="half_rhythm"><div><b>Pre-pregnancy</b></div><ul><li class="half_rhythm"><div>Counseling that emphasizes the importance of frequent eating in preventing hypoglycemia and the use of blood glucose monitoring for early detection of hypoglycemia</div></li><li class="half_rhythm"><div>Consider referral to a high-risk obstetric center and consultation with a metabolic physician.</div></li></ul></li><li class="half_rhythm"><div><b>During pregnancy</b></div><ul><li class="half_rhythm"><div>Close home glucose monitoring for early detection of hypoglycemia</div></li><li class="half_rhythm"><div>Maintenance of glycemic control by taking uncooked cornstarch at night as needed [<a class="bk_pop" href="#fructose1-6-def.REF.krishnamurthy.2007.819">Krishnamurthy et al 2007</a>, <a class="bk_pop" href="#fructose1-6-def.REF.sugita.2014.115">Sugita et al 2014</a>]</div></li><li class="half_rhythm"><div>In the third trimester when the physiologic requirements of energy are highest, increase in dietary intake and glucose monitoring as needed</div></li></ul></li><li class="half_rhythm"><div><b>During labor.</b> Continuous glucose infusion to maintain euglycemia</div></li></ul></div><div id="fructose1-6-def.Therapies_Under_Investig"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="fructose1-6-def.Genetic_Counseling"><h2 id="_fructose1-6-def_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="fructose1-6-def.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Fructose-1,6-bisphosphatase (FBP1) deficiency is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., presumed to be carriers of one <i>FBP1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> based on family history).</div></li><li class="half_rhythm"><div>Molecular genetic testing is recommended for the parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> to confirm that each parent is <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for an <i>FBP1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and to allow reliable <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> assessment. (Although a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant has not been reported in FBP1 deficiency to date, <i>de novo</i> variants are known to occur at a low but appreciable rate in <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> disorders [<a class="bk_pop" href="#fructose1-6-def.REF.j_nsson.2017.519">J&#x000f3;nsson et al 2017</a>].)</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>If each parent is known to be <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for an <i>FBP1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, each sib at conception has a 25% chance of being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Unless an individual with FBP1 deficiency has children with an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual or a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, his/her offspring will be obligate heterozygotes (carriers) for one of the <i>FBP1</i> pathogenic variants identified in the proband<i>.</i></p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of an <i>FBP1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="fructose1-6-def.Carrier_Heterozygote_Det"><h3>Carrier (Heterozygote) Detection</h3><p><b>Molecular genetic testing.</b> Carrier testing for at-risk relatives requires prior identification of the <i>FBP1</i> pathogenic variants in the family.</p><p>Note: Biochemical enzyme-based testing is not reliable for <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> detection.</p></div><div id="fructose1-6-def.Related_Genetic_Counseli"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#fructose1-6-def.Evaluation_of_Relatives">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="fructose1-6-def.Prenatal_Testing_and_Pre"><h3>Prenatal Testing and Preimplantation Genetic Testing</h3><p><b>Molecular genetic testing.</b> Once the <i>FBP1</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-testing/">preimplantation genetic testing</a> are possible.</p><p>Note: Biochemical testing is not a reliable method for <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> as FBP1 enzyme activity has been reported to be low in human placenta [<a class="bk_pop" href="#fructose1-6-def.REF.papamarcaki.1991.67">Papamarcaki &#x00026; Tsolas 1991</a>].</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="fructose1-6-def.Resources"><h2 id="_fructose1-6-def_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Metabolic Support UK</b></div><div>5 Hilliards Court, Sandpiper Way</div><div>Chester Business Park</div><div>Chester CH4 9QP </div><div>United Kingdom</div><div><b>Phone:</b> 0845 241 2173</div><div><b>Email:</b> contact@metabolicsupportuk.org</div><div><a href="https://www.metabolicsupportuk.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.metabolicsupportuk.org</a></div></li></ul></div><div id="fructose1-6-def.Molecular_Genetics"><h2 id="_fructose1-6-def_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="fructose1-6-def.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Fructose-1,6-Bisphosphatase Deficiency: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK550349/table/fructose1-6-def.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__fructose1-6-def.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_fructose1-6-def.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_fructose1-6-def.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_fructose1-6-def.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_fructose1-6-def.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_fructose1-6-def.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_fructose1-6-def.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_fructose1-6-def.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/2203" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>FBP1</i></a></td><td headers="hd_b_fructose1-6-def.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=2203" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">9q22<wbr style="display:inline-block"></wbr>​.32</a></td><td headers="hd_b_fructose1-6-def.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P09467" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Fructose-1,6-bisphosphatase 1</a></td><td headers="hd_b_fructose1-6-def.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/FBP1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FBP1 database</a></td><td headers="hd_b_fructose1-6-def.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=FBP1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FBP1</a></td><td headers="hd_b_fructose1-6-def.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=FBP1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FBP1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="fructose1-6-def.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="fructose1-6-def.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Fructose-1,6-Bisphosphatase Deficiency (<a href="/omim/229700,611570" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK550349/table/fructose1-6-def.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__fructose1-6-def.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/229700" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">229700</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY; FBP1D</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/611570" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">611570</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">FRUCTOSE-1,6-BISPHOSPHATASE 1; FBP1</td></tr></tbody></table></div></div><div id="fructose1-6-def.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>Fructose-1,6-bisphosphatase 1 (FBPase, or FBP1) is a key enzyme of the gluconeogenic pathway. Its deficiency impairs glucose production from all gluconeogenic precursors, including dietary fructose. As a result, euglycemia in persons with FBP1 deficiency depends on glycogen stores in the liver. During glycemic stress (including catabolic states such as infections and fasting), glycogen stores are depleted and the gluconeogenic substrates pyruvate, alanine, and glycerol accumulate (<a class="figpopup" href="/books/NBK550349/figure/fructose1-6-def.F1/?report=objectonly" target="object" rid-figpopup="figfructose16defF1" rid-ob="figobfructose16defF1">Figure 1</a>). The subsequent conversion of pyruvate into lactate and acetyl CoA results in lactic acidemia and ketosis.</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figfructose16defF1" co-legend-rid="figlgndfructose16defF1"><a href="/books/NBK550349/figure/fructose1-6-def.F1/?report=objectonly" target="object" title="Figure 1: " class="img_link icnblk_img figpopup" rid-figpopup="figfructose16defF1" rid-ob="figobfructose16defF1"><img class="small-thumb" src="/books/NBK550349/bin/fructose1-6-def-Image001.gif" src-large="/books/NBK550349/bin/fructose1-6-def-Image001.jpg" alt="Figure 1: " /></a><div class="icnblk_cntnt" id="figlgndfructose16defF1"><h4 id="fructose1-6-def.F1"><a href="/books/NBK550349/figure/fructose1-6-def.F1/?report=objectonly" target="object" rid-ob="figobfructose16defF1">Figure 1: </a></h4><p class="float-caption no_bottom_margin">Pathophysiology of FBP1 deficiency </p></div></div><p>Deficient conversion of glucose-1-phosphate to glucose also activates the pentose phosphate pathway, causing both the production of ribose-5-phosphate and the synthesis of purines and pyrimidines. The subsequent breakdown of purines and pyrimidines results in hyperuricemia.</p><p><b>Mechanism of disease causation.</b> Loss of fructose-1,6-bisphosphatase 1 function</p><p><b><i>FBP1</i>-specific laboratory technical considerations.</b>
<i>FBP1</i> comprises one noncoding <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> (exon 1) and seven coding exons; it spans more than 31 kb [<a class="bk_pop" href="#fructose1-6-def.REF.elmaghrabi.1995.520">el-Maghrabi et al 1995</a>]. Deletions of exons 2, 3, 3-7, and 8 as well as whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions have been reported.</p><p>(The six <i>FBP1</i> introns are in the same positions in the rat <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.)</p><div id="fructose1-6-def.T.notable_fbp1_pathogeni" class="table"><h3><span class="label">Table 7. </span></h3><div class="caption"><p>Notable <i>FBP1</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK550349/table/fructose1-6-def.T.notable_fbp1_pathogeni/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__fructose1-6-def.T.notable_fbp1_pathogeni_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_fructose1-6-def.T.notable_fbp1_pathogeni_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th><th id="hd_h_fructose1-6-def.T.notable_fbp1_pathogeni_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide<br />Change</th><th id="hd_h_fructose1-6-def.T.notable_fbp1_pathogeni_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted<br />Protein Change</th><th id="hd_h_fructose1-6-def.T.notable_fbp1_pathogeni_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment [Reference]</th></tr></thead><tbody><tr><td headers="hd_h_fructose1-6-def.T.notable_fbp1_pathogeni_1_1_1_1" rowspan="6" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000507.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000507<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_000498.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000498<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_h_fructose1-6-def.T.notable_fbp1_pathogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.-24-26_170+5192 (<a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 2)</td><td headers="hd_h_fructose1-6-def.T.notable_fbp1_pathogeni_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_fructose1-6-def.T.notable_fbp1_pathogeni_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Observed in the <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> state in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> persons in Armenia &#x00026; Turkey [<a class="bk_pop" href="#fructose1-6-def.REF.santer.2016.44">Santer et al 2016</a>]</td></tr><tr><td headers="hd_h_fructose1-6-def.T.notable_fbp1_pathogeni_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.472C&#x0003e;T</td><td headers="hd_h_fructose1-6-def.T.notable_fbp1_pathogeni_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg158Trp</td><td headers="hd_h_fructose1-6-def.T.notable_fbp1_pathogeni_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequently observed in France, India, Pakistan, Saudi Arabia, &#x00026; Brazil [<a class="bk_pop" href="#fructose1-6-def.REF.lebigot.2015.881">Lebigot et al 2015</a>, <a class="bk_pop" href="#fructose1-6-def.REF.ijaz.2017.1203">Ijaz et al 2017</a>, <a class="bk_pop" href="#fructose1-6-def.REF.bhai.2018.309">Bhai et al 2018</a>, <a class="bk_pop" href="#fructose1-6-def.REF.moey.2018.397">Moey et al 2018</a>, <a class="bk_pop" href="#fructose1-6-def.REF.pinheiro.2019.102">Pinheiro et al 2019</a>]</td></tr><tr><td headers="hd_h_fructose1-6-def.T.notable_fbp1_pathogeni_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.611_614delAAAA</td><td headers="hd_h_fructose1-6-def.T.notable_fbp1_pathogeni_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Lys204ArgfsTer72</td><td headers="hd_h_fructose1-6-def.T.notable_fbp1_pathogeni_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Observed in India &#x00026; Pakistan [<a class="bk_pop" href="#fructose1-6-def.REF.ijaz.2017.1203">Ijaz et al 2017</a>, <a class="bk_pop" href="#fructose1-6-def.REF.bhai.2018.309">Bhai et al 2018</a>]</td></tr><tr><td headers="hd_h_fructose1-6-def.T.notable_fbp1_pathogeni_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.685C&#x0003e;T</td><td headers="hd_h_fructose1-6-def.T.notable_fbp1_pathogeni_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu229Ter</td><td headers="hd_h_fructose1-6-def.T.notable_fbp1_pathogeni_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Common in Morocco [<a class="bk_pop" href="#fructose1-6-def.REF.prahl.2006.4014">Prahl et al 2006</a>, <a class="bk_pop" href="#fructose1-6-def.REF.lebigot.2015.881">Lebigot et al 2015</a>]</td></tr><tr><td headers="hd_h_fructose1-6-def.T.notable_fbp1_pathogeni_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.841G&#x0003e;A</td><td headers="hd_h_fructose1-6-def.T.notable_fbp1_pathogeni_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu281Lys</td><td headers="hd_h_fructose1-6-def.T.notable_fbp1_pathogeni_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Common in India, Pakistan, &#x00026; Saudi Arabia [<a class="bk_pop" href="#fructose1-6-def.REF.afroze.2013.1249">Afroze et al 2013</a>, <a class="bk_pop" href="#fructose1-6-def.REF.santer.2016.44">Santer et al 2016</a>, <a class="bk_pop" href="#fructose1-6-def.REF.ijaz.2017.1203">Ijaz et al 2017</a>, <a class="bk_pop" href="#fructose1-6-def.REF.bhai.2018.309">Bhai et al 2018</a>]</td></tr><tr><td headers="hd_h_fructose1-6-def.T.notable_fbp1_pathogeni_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c. 959dupG</td><td headers="hd_h_fructose1-6-def.T.notable_fbp1_pathogeni_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser321ValfsTer13</td><td headers="hd_h_fructose1-6-def.T.notable_fbp1_pathogeni_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Common in Japan; observed in China, Korea, &#x00026; in North Americans &#x00026; Europeans [<a class="bk_pop" href="#fructose1-6-def.REF.kikawa.1997.852">Kikawa et al 1997</a>, <a class="bk_pop" href="#fructose1-6-def.REF.herzog.2001.87">Herzog et al 2001</a>, <a class="bk_pop" href="#fructose1-6-def.REF.takagi.2013.761">Takagi et al 2013</a>, <a class="bk_pop" href="#fructose1-6-def.REF.lee.2019.533">Lee et al 2019</a>]</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div></div></div><div id="fructose1-6-def.References"><h2 id="_fructose1-6-def_References_">References</h2><div id="fructose1-6-def.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="fructose1-6-def.REF.afroze.2013.1249">Afroze B, Yunus Z, Steinmann B, Santer R. Transient pseudo-hypertriglyceridemia: a useful biochemical marker of fructose-1,6-bisphosphatase deficiency. <span><span class="ref-journal">Eur J Pediatr. </span>2013;<span class="ref-vol">172</span>:1249–53.</span> [<a href="/pubmed/23881342" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23881342</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fructose1-6-def.REF._sberg.2010.s113">&#x000c5;sberg C, Hjalmarson O, Alm J, Martinsson T, Waldenstr&#x000f6;m J, Hellerud C. Fructose 1,6-bisphosphatase deficiency: enzyme and mutation analysis performed on calcitriol-stimulated monocytes with a note on long-term prognosis. <span><span class="ref-journal">J Inherit Metab Dis. </span>2010;<span class="ref-vol">33</span>:S113–21.</span> [<a href="/pubmed/20151204" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20151204</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fructose1-6-def.REF.baker.1970.13">Baker L, Winegrad AI. Fasting hypoglycaemia and metabolic acidosis associated with deficiency of hepatic fructose-1,6-diphosphatase activity. <span><span class="ref-journal">Lancet. </span>1970;<span class="ref-vol">2</span>:13–6.</span> [<a href="/pubmed/4193749" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 4193749</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fructose1-6-def.REF.besley.1994.333">Besley GT, Walter JH, Lewis MA, Chard CR, Addison GM. Fructose-1,6-bisphosphatase deficiency: severe phenotype with normal leukocyte enzyme activity. <span><span class="ref-journal">J Inherit Metab Dis. </span>1994;<span class="ref-vol">17</span>:333–5.</span> [<a href="/pubmed/7807945" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7807945</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fructose1-6-def.REF.bhai.2018.309">Bhai P, Bijarnia-Mahay S, Puri RD, Saxena R, Gupta D, Kotecha U, Sachdev A, Gupta D, Vyas V, Agarwal D, Jain V, Bansal RK, Kumar TG, Verma IC. Clinical and molecular characterization of Indian patients with fructose-1, 6-bisphosphatase deficiency: identification of a frequent variant (E281K). <span><span class="ref-journal">Ann Hum Genet. </span>2018;<span class="ref-vol">82</span>:309–17.</span> [<a href="/pubmed/29774539" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29774539</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fructose1-6-def.REF.cole.1990.1267">Cole TG. Glycerol blanking in triglyceride assays: is it necessary? <span><span class="ref-journal">Clin Chem. </span>1990;<span class="ref-vol">36</span>:1267–8.</span> [<a href="/pubmed/2136327" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2136327</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fructose1-6-def.REF.elmaghrabi.1995.520">el-Maghrabi MR, Lange AJ, Jiang W, Yamagata K, Stoffel M, Takeda J, Fernald AA, Le Beau MM, Bell GI, Baker L, et al.  Human fructose-1,6-bisphosphatase gene (FBP1): exon-intron organization, localization to chromosome bands 9q22.2-q22.3, and mutation screening in subjects with fructose-1,6-bisphosphatase deficiency. <span><span class="ref-journal">Genomics. </span>1995;<span class="ref-vol">27</span>:520–5.</span> [<a href="/pubmed/7558035" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7558035</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fructose1-6-def.REF.herzog.2001.87">Herzog B, Morris AA, Saunders C, Eschrich K. Mutation spectrum in patients with fructose-1,6-bisphosphatase deficiency. <span><span class="ref-journal">J Inherit Metab Dis. </span>2001;<span class="ref-vol">24</span>:87–8.</span> [<a href="/pubmed/11286391" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11286391</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fructose1-6-def.REF.ijaz.2017.1203">Ijaz S, Zahoor MY, Imran M, Ramzan K, Bhinder MA, Shakeel H, Iqbal M, Aslam A, Shehzad W, Cheema HA, Rehman H. Genetic analysis of fructose-1,6-bisphosphatase (FBPase) deficiency in nine consanguineous Pakistani families. <span><span class="ref-journal">J Pediatr Endocrinol Metab. </span>2017;<span class="ref-vol">30</span>:1203–10.</span> [<a href="/pubmed/29016355" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29016355</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fructose1-6-def.REF.j_nsson.2017.519">J&#x000f3;nsson H, Sulem P, Kehr B, Kristmundsdottir S, Zink F, Hjartarson E, Hardarson MT, Hjorleifsson KE, Eggertsson HP, Gudjonsson SA, Ward LD, Arnadottir GA, Helgason EA, Helgason H, Gylfason A, Jonasdottir A, Jonasdottir A, Rafnar T, Frigge M, Stacey SN, Th Magnusson O, Thorsteinsdottir U, Masson G, Kong A, Halldorsson BV, Helgason A, Gudbjartsson DF, Stefansson K. Parental influence on human germline de novo mutations in 1,548 trios from Iceland. <span><span class="ref-journal">Nature. </span>2017;<span class="ref-vol">549</span>:519–22.</span> [<a href="/pubmed/28959963" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28959963</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fructose1-6-def.REF.kikawa.1997.852">Kikawa Y, Inuzuka M, Jin BY, Kaji S, Koga J, Yamamoto Y, Fujisawa K, Hata I, Nakai A, Shigematsu Y, Mizunuma H, Taketo A, Mayumi M, Sudo M. Identification of genetic mutations in Japanese patients with fructose-1,6-bisphosphatase deficiency. <span><span class="ref-journal">Am J Hum Genet. </span>1997;<span class="ref-vol">61</span>:852–61.</span> [<a href="/pmc/articles/PMC1715983/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1715983</span></a>] [<a href="/pubmed/9382095" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9382095</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fructose1-6-def.REF.krishnamurthy.2007.819">Krishnamurthy V, Eschrich K, Boney A, Sullivan J, McDonald M, Kishnani PS, Koeberl DD. Three successful pregnancies through dietary management of fructose-1,6-bisphosphatase deficiency. <span><span class="ref-journal">J Inherit Metab Dis. </span>2007;<span class="ref-vol">30</span>:819.</span> [<a href="/pubmed/17705024" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17705024</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fructose1-6-def.REF.lebigot.2015.881">Lebigot E, Brassier A, Zater M, Imanci D, Feillet F, Th&#x000e9;rond P, de Lonlay P, Boutron A. Fructose 1,6-bisphosphatase deficiency: clinical, biochemical and genetic features in French patients. <span><span class="ref-journal">J Inherit Metab Dis. </span>2015;<span class="ref-vol">38</span>:881–7.</span> [<a href="/pubmed/25601412" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25601412</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fructose1-6-def.REF.lee.2019.533">Lee H, Kwon A, Kim HS, Lee JS. Fructose-1,6-bisphosphatase deficiency presented with complex febrile convulsion. <span><span class="ref-journal">Neuro Endocrinol Lett. </span>2019;<span class="ref-vol">39</span>:533–6.</span> [<a href="/pubmed/30927757" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30927757</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fructose1-6-def.REF.li.2017.e857">Li N, Chang G, Xu Y, Ding Y, Li G, Yu T, Qing Y, Li J, Shen Y, Wang J, Wang X. Clinical and molecular characterization of patients with fructose 1,6-bisphosphatase deficiency. <span><span class="ref-journal">Int J Mol Sci. </span>2017;<span class="ref-vol">18</span>:E857</span> [<a href="/pmc/articles/PMC5412439/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5412439</span></a>] [<a href="/pubmed/28420223" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28420223</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fructose1-6-def.REF.moey.2018.397">Moey LH, Abdul Azize NA, Yakob Y, Leong HY, Keng WT, Chen BC, Ngu LH. Fructose-1,6-bisphosphatase deficiency as a cause of recurrent hypoglycemia and metabolic acidosis: clinical and molecular findings in Malaysian patients. <span><span class="ref-journal">Pediatr Neonatol. </span>2018;<span class="ref-vol">59</span>:397–403.</span> [<a href="/pubmed/29203193" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29203193</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fructose1-6-def.REF.nakai.1993.408">Nakai A, Shigematsu Y, Liu YY, Kikawa Y, Sudo M. Urinary sugar phosphates and related organic acids in fructose-1,6-diphosphatase deficiency. <span><span class="ref-journal">J Inherit Metab Dis. </span>1993;<span class="ref-vol">16</span>:408–14.</span> [<a href="/pubmed/8412001" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8412001</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fructose1-6-def.REF.papamarcaki.1991.67">Papamarcaki T, Tsolas O. Demonstration of fructose 1,6-bisphosphatase in human term placenta. <span><span class="ref-journal">Experientia. </span>1991;<span class="ref-vol">47</span>:67–8.</span> [<a href="/pubmed/1847882" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1847882</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fructose1-6-def.REF.pinheiro.2019.102">Pinheiro FC, Sperb-Ludwig F, Ligabue-Braun R, Sch&#x000fc;ler-Faccini L, de Souza CFM, Vairo F, Schwartz IVD. Genetic analysis of patients with fructose-1,6-bisphosphatase deficiency. <span><span class="ref-journal">Gene. </span>2019;<span class="ref-vol">699</span>:102–9.</span> [<a href="/pubmed/30858132" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30858132</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fructose1-6-def.REF.pinto.2018.21">Pinto A, Alfadhel M, Akroyd R, Atik Alt&#x00131;nok Y, Bernabei SM, Bernstein L, Bruni G, Caine G, Cameron E, Carruthers R, Cochrane B, Daly A, de Boer F, Delaunay S, Dianin A, Dixon M, Drogari E, Dubois S, Evans S, Gribben J, Gugelmo G, Heidenborg C, Hunjan I, Kok IL, Kumru B, Liguori A, Mayr D, Megdad E, Meyer U, Oliveira RB, Pal A, Pozzoli A, Pretese R, Rocha JC, Rosenbaum-Fabian S, Serrano-Nieto J, Sjoqvist E, Timmer C, White L, van den Hurk T, van Rijn M, Zweers H, Ziadlou M, MacDonald A. International practices in the dietary management of fructose 1-6 biphosphatase deficiency. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2018;<span class="ref-vol">13</span>:21.</span> [<a href="/pmc/articles/PMC5785792/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5785792</span></a>] [<a href="/pubmed/29370874" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29370874</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fructose1-6-def.REF.prahl.2006.4014">Prahl P, Christensen E, Hansen L, Mortensen HB. Fructose 1,6-bisphosphatase deficiency as a cause of recessive serious hypoglycaemia. <span><span class="ref-journal">Ugeskr Laeger. </span>2006;<span class="ref-vol">168</span>:4014–5.</span> [<a href="/pubmed/17125659" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17125659</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fructose1-6-def.REF.santer.2016.44">Santer R, du Moulin M, Shahinyan T, Vater I, Maier E, Muntau AC, Steinmann B. A summary of molecular genetic findings in fructose-1,6-bisphosphatase deficiency with a focus on a common long-range deletion and the role of MLPA analysis. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2016;<span class="ref-vol">11</span>:44.</span> [<a href="/pmc/articles/PMC4839065/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4839065</span></a>] [<a href="/pubmed/27101822" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27101822</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fructose1-6-def.REF.steinmann.2016">Steinmann B, Santer R. Disorders of fructose metabolism. In: Saudubray JM, ed. <em>Inborn Metabolic Diseases</em>. 6 ed. Springer-Verlag; 2016:165&#x02013;7.</div></li><li class="half_rhythm"><div class="bk_ref" id="fructose1-6-def.REF.sugita.2014.115">Sugita G, Tsuyoshi H, Nishijima K, Yoshida Y. Fructose-1,6-bisphosphatase deficiency: a case of a successful pregnancy by closely monitoring metabolic control. <span><span class="ref-journal">JIMD Rep. </span>2014;<span class="ref-vol">14</span>:115–8.</span> [<a href="/pmc/articles/PMC4213334/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4213334</span></a>] [<a href="/pubmed/24470127" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24470127</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fructose1-6-def.REF.takagi.2013.761">Takagi D, Ben-Ari J, Nemet D, Zeharia A, Eliakim A. Recurrent infantile hypoglycemia due to combined fructose-1,6-diphosphatase deficiency and growth hormone deficiency. <span><span class="ref-journal">J Pediatr Endocrinol Metab. </span>2013;<span class="ref-vol">26</span>:761–3.</span> [<a href="/pubmed/23585210" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23585210</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="fructose1-6-def.REF.visser.2004.207">Visser G, Bakker HD, de Klerk JBC, Smeitink JAM, Smit GPA, Wijburg FA. Natural history and treatment of fructose-1,6,-bisphosphatase deficiency in the Netherlands. <span><span class="ref-journal">J Inherit Metab Dis. </span>2004;<span class="ref-vol">27</span>:207.</span> (abstract)</div></li><li class="half_rhythm"><div class="bk_ref" id="fructose1-6-def.REF.wang.2017.7273">Wang S, Sun J, Kong X, Yang C, Feng Z. Fructose 1,6-bisphosphatase deficiency: clinical manifestations and genetic features in two Chinese patients. <span><span class="ref-journal">Int J Clin Exp Med. </span>2017;<span class="ref-vol">10</span>:7273–8.</span></div></li></ul></div></div><div id="fructose1-6-def.Chapter_Notes"><h2 id="_fructose1-6-def_Chapter_Notes_">Chapter Notes</h2><div id="fructose1-6-def.Acknowledgments"><h3>Acknowledgments</h3><p>The authors would like to acknowledge our senior colleagues, Dr Ishwar Chander Verma, Dr Ratna D Puri, and Dr Renu Saxena, for rendering support in writing this article. Significant contributions from other colleagues, Dr Pratibha Bhai, Dr Deepti Gupta, Dr Ranjana Mishra, Dr Vibha Jain, and Dr Jyotsna Verma, are also gratefully acknowledged.</p></div><div id="fructose1-6-def.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>5 December 2019 (bp) Review posted live</div></li><li class="half_rhythm"><div>20 May 2019 (sb) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK550349</span><span class="label">PMID: <a href="/pubmed/31804789" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">31804789</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/ftd-chmp2b/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/fryns/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK550349&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK550349/?report=reader">PubReader</a></li><li><a href="/books/NBK550349/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK550349" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK550349" style="display:none" title="Cite this Page"><div class="bk_tt">Bijarnia-Mahay S, Bhatia S, Arora V. Fructose-1,6-Bisphosphatase Deficiency. 2019 Dec 5. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK550349/pdf/Bookshelf_NBK550349.pdf">PDF version of this page</a> (661K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#fructose1-6-def.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#fructose1-6-def.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#fructose1-6-def.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#fructose1-6-def.Genetically_Related_Alle" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#fructose1-6-def.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#fructose1-6-def.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#fructose1-6-def.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#fructose1-6-def.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#fructose1-6-def.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#fructose1-6-def.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#fructose1-6-def.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=2203[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">FBP1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=4888732" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4888732" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4888732" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=4888732" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24006547" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Ornithine Transcarbamylase Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Ornithine Transcarbamylase Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lichter-Konecki U, Caldovic L, Morizono H, Simpson K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/22593918" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Propionic Acidemia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Propionic Acidemia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Shchelochkov OA, Carrillo N, Venditti C. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29369572" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">TANGO2</i>-Related Metabolic Encephalopathy and Arrhythmias</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">TANGO2</i>-Related Metabolic Encephalopathy and Arrhythmias<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lalani SR, Graham B, Burrage L, Lai YC, Scaglia F, Soler-Alfonso C, Miyake C, Yang Y. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301788" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glycogen Storage Disease Type III</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glycogen Storage Disease Type III<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Dagli A, Sentner CP, Weinstein DA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/21634085" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Phosphorylase Kinase Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Phosphorylase Kinase Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Herbert M, Goldstein JL, Rehder C, Austin S, Kishnani PS, Bali DS. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=31804789" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=31804789" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e0412fa75f66d18aafe9f28">Fructose-1,6-Bisphosphatase Deficiency - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Fructose-1,6-Bisphosphatase Deficiency - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:55:06-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal102&amp;ncbi_phid=CE890F24E04071E10000000005CC0296&amp;ncbi_session=CE890F24E0412FA1_1484SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK550349%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK550349&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK550349/&amp;ncbi_pagename=Fructose-1,6-Bisphosphatase Deficiency - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE890F24E0412FA1_1484SID /projects/books/PBooks@5.22 portal102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>